Pharmaceutical preparation for the treatment of psoriatic arthritis
US4959389A · kind A · utility
70Cited by
0References
2Claims
0Family size
Inventors
Key dates
| Filing date | Oct 19, 1987 |
| Grant date | Sep 25, 1990 |
| Priority date | — |
| Expiry date | Oct 19, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/225
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition including at least one salt of fumaric acid monoalkyl ester having the formula: ##STR1## alone or in combination with dialkyl fumarate having the formula: ##STR2## is provided for treatment of psoriasis and psoriatic arthritis. In particular, use of the calcium salt of fumaric acid monoalkyl ester in the composition is desirable.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.